LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of LianBio - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. LianBio - ADR market cap is $35.87M.
What is the 52-week high for LianBio - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. LianBio - ADR 52 week high is $0.3888 as of June 07, 2024.
What is the 52-week low for LianBio - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. LianBio - ADR 52 week low is $0.0506 as of June 07, 2024.
What is LianBio - ADR stock price today?
LianBio - ADR stock price today is $0.33.
What was LianBio - ADR stock price yesterday?
LianBio - ADR stock price yesterday was $0.3327.
What is the PE ratio of LianBio - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. LianBio - ADR’s P/E ratio is 0.11.
What is the Price-to-Book ratio of LianBio - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. LianBio - ADR P/B ratio is 0.0617.
What is LianBio - ADR's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. LianBio - ADR's EBITDA is 0.83.
What is the 50-day moving average of LianBio - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. LianBio - ADR 50-day moving average is $0.3114.